{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:24:22Z","timestamp":1783340662046,"version":"3.54.6"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03078-2","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:51:50Z","timestamp":1741629110000},"page":"485-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of venous thromboembolic events in hospitalized patients with COVID-19"],"prefix":"10.1007","volume":"58","author":[{"given":"Giovanni","family":"Scimeca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darsiya","family":"Krishnathasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Rashedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Hamade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bejjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candrika D.","family":"Khairani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Porio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Armero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Tristani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos D.","family":"Ortiz-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Nauffal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Almarzooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Zuluaga-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Achanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirus J.","family":"Jesudasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geno J.","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fanikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana B.","family":"Pfeferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth B.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Vishnevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Nehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Welker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Campia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"7","key":"3078_CR1","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/rth2.12439","volume":"4","author":"S Nopp","year":"2020","unstructured":"Nopp S et al (2020) Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 4(7):1178\u20131191. https:\/\/doi.org\/10.1002\/rth2.12439","journal-title":"Res Pract Thromb Haemost"},{"issue":"18","key":"3078_CR2","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","volume":"76","author":"G Piazza","year":"2020","unstructured":"Piazza G et al (2020) Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol 76(18):2060\u20132072. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.070","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3078_CR3","doi-asserted-by":"publisher","first-page":"e232338","DOI":"10.1001\/jamanetworkopen.2023.2338","volume":"6","author":"MC Fang","year":"2023","unstructured":"Fang MC et al (2023) Assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19. JAMA Netw Open 6(3):e232338. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.2338","journal-title":"JAMA Netw Open"},{"issue":"19","key":"3078_CR4","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL et al (2020) American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693\u20134738. https:\/\/doi.org\/10.1182\/bloodadvances.2020001830","journal-title":"Blood Adv"},{"issue":"24","key":"3078_CR5","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1001\/jama.2020.23422","volume":"324","author":"G Piazza","year":"2020","unstructured":"Piazza G, Morrow DA (2020) Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA 324(24):2548\u20132549. https:\/\/doi.org\/10.1001\/jama.2020.23422","journal-title":"JAMA"},{"issue":"3","key":"3078_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MEJ.0000000000000783","volume":"28","author":"S Jimenez","year":"2021","unstructured":"Jimenez S et al (2021) Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the emergency department: results of the UMC-19-S8. Eur J Emerg Med 28(3):218\u2013226. https:\/\/doi.org\/10.1097\/MEJ.0000000000000783","journal-title":"Eur J Emerg Med"},{"issue":"1","key":"3078_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11239-020-02181-w","volume":"51","author":"S Chen","year":"2021","unstructured":"Chen S et al (2021) DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis 51(1):33\u201339. https:\/\/doi.org\/10.1007\/s11239-020-02181-w","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"3078_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/jth.15261","volume":"19","author":"JY Li","year":"2021","unstructured":"Li JY et al (2021) Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. J Thromb Haemost 19(4):1038\u20131048. https:\/\/doi.org\/10.1111\/jth.15261","journal-title":"J Thromb Haemost"},{"key":"3078_CR9","doi-asserted-by":"publisher","unstructured":"Lobbes H et al (2021) Risk factors for venous thromboembolism in severe COVID-19: A Study-Level Meta-Analysis of 21 studies. Int J Environ Res Public Health 18(24). https:\/\/doi.org\/10.3390\/ijerph182412944","DOI":"10.3390\/ijerph182412944"},{"issue":"17","key":"3078_CR10","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1182\/bloodadvances.2022007561","volume":"6","author":"A Cuker","year":"2022","unstructured":"Cuker A et al (2022) American society of hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Adv 6(17):4915\u20134923. https:\/\/doi.org\/10.1182\/bloodadvances.2022007561","journal-title":"Blood Adv"},{"issue":"17","key":"3078_CR11","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1182\/bloodadvances.2022007940","volume":"6","author":"A Cuker","year":"2022","unstructured":"Cuker A et al (2022) American society of hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Adv 6(17):4975\u20134982. https:\/\/doi.org\/10.1182\/bloodadvances.2022007940","journal-title":"Blood Adv"},{"key":"3078_CR12","doi-asserted-by":"publisher","unstructured":"Schulman S et al (2023) ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost, 2024. 22(6): pp. 1779\u20131797 https:\/\/doi.org\/10.1016\/j.jtha.2024.02.011","DOI":"10.1016\/j.jtha.2024.02.011"},{"issue":"18","key":"3078_CR13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2023.02.041","volume":"81","author":"GW Stone","year":"2023","unstructured":"Stone GW et al (2023) Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19. J Am Coll Cardiol 81(18):1747\u20131762. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.041","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3078_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00408-023-00599-6","volume":"201","author":"E Pilia","year":"2023","unstructured":"Pilia E et al (2023) The effect of heparin Full-Dose anticoagulation on survival of hospitalized, Non-critically ill COVID-19 patients: A Meta-analysis of high quality studies. Lung 201(2):135\u2013147. https:\/\/doi.org\/10.1007\/s00408-023-00599-6","journal-title":"Lung"},{"key":"3078_CR15","doi-asserted-by":"publisher","unstructured":"Munoz-Rivas N et al (2022) Efficacy and safety of Tinzaparin in prophylactic, intermediate and therapeutic doses in Non-Critically ill patients hospitalized with COVID-19: the PROTHROMCOVID randomized controlled trial. J Clin Med 11(19). https:\/\/doi.org\/10.3390\/jcm11195632","DOI":"10.3390\/jcm11195632"},{"key":"3078_CR16","doi-asserted-by":"publisher","first-page":"102031","DOI":"10.1016\/j.eclinm.2023.102031","volume":"60","author":"S Zuily","year":"2023","unstructured":"Zuily S et al (2023) Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial. EClinicalMedicine 60:102031. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102031","journal-title":"EClinicalMedicine"},{"issue":"2","key":"3078_CR17","first-page":"11","volume":"70","author":"D Kumar","year":"2022","unstructured":"Kumar D et al (2022) Oral Rivaroxaban in the prophylaxis of COVID-19 induced coagulopathy. J Assoc Physicians India 70(2):11\u201312","journal-title":"J Assoc Physicians India"},{"issue":"7","key":"3078_CR18","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1002\/jmv.26918","volume":"93","author":"C Kirkup","year":"2021","unstructured":"Kirkup C et al (2021) Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry. J Med Virol 93(7):4303\u20134318. https:\/\/doi.org\/10.1002\/jmv.26918","journal-title":"J Med Virol"},{"issue":"6","key":"3078_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamainternmed.2023.0456","volume":"183","author":"V Labbe","year":"2023","unstructured":"Labbe V et al (2023) Effects of Standard-Dose prophylactic, High-Dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID randomized clinical trial. JAMA Intern Med 183(6):520\u2013531. https:\/\/doi.org\/10.1001\/jamainternmed.2023.0456","journal-title":"JAMA Intern Med"},{"issue":"5","key":"3078_CR20","doi-asserted-by":"publisher","first-page":"e13735","DOI":"10.1111\/eci.13735","volume":"52","author":"N Morici","year":"2022","unstructured":"Morici N et al (2022) Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: the X-COVID-19 randomized trial. Eur J Clin Invest 52(5):e13735. https:\/\/doi.org\/10.1111\/eci.13735","journal-title":"Eur J Clin Invest"},{"issue":"18","key":"3078_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/CIRCULATIONAHA.122.061533","volume":"146","author":"EA Bohula","year":"2022","unstructured":"Bohula EA et al (2022) Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-PACT. Circulation 146(18):1344\u20131356. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061533","journal-title":"Circulation"},{"key":"3078_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.thromres.2020.11.017","volume":"198","author":"F Scudiero","year":"2021","unstructured":"Scudiero F et al (2021) Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res 198:34\u201339. https:\/\/doi.org\/10.1016\/j.thromres.2020.11.017","journal-title":"Thromb Res"},{"issue":"4","key":"3078_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.chest.2021.07.025","volume":"160","author":"AS Go","year":"2021","unstructured":"Go AS et al (2021) COVID-19 and risk of VTE in ethnically diverse populations. Chest 160(4):1459\u20131470. https:\/\/doi.org\/10.1016\/j.chest.2021.07.025","journal-title":"Chest"},{"issue":"8","key":"3078_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/crj.13377","volume":"15","author":"DH Barnes","year":"2021","unstructured":"Barnes DH et al (2021) Predictors of venous thromboembolism in patients with COVID-19 in an underserved urban population: A single tertiary center experience. Clin Respir J 15(8):885\u2013891. https:\/\/doi.org\/10.1111\/crj.13377","journal-title":"Clin Respir J"},{"key":"3078_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fmed.2020.00557","volume":"7","author":"N Benito","year":"2020","unstructured":"Benito N et al (2020) Pulmonary thrombosis or embolism in a large cohort of hospitalized patients with Covid-19. Front Med (Lausanne) 7:557. https:\/\/doi.org\/10.3389\/fmed.2020.00557","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"3078_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1055\/a-1366-9656","volume":"121","author":"SL Cohen","year":"2021","unstructured":"Cohen SL et al (2021) Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients. Thromb Haemost 121(8):1043\u20131053. https:\/\/doi.org\/10.1055\/a-1366-9656","journal-title":"Thromb Haemost"},{"issue":"32","key":"3078_CR27","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/eurheartj\/ehaa500","volume":"41","author":"C Fauvel","year":"2020","unstructured":"Fauvel C et al (2020) Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J 41(32):3058\u20133068. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa500","journal-title":"Eur Heart J"},{"issue":"1","key":"3078_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12931-023-02369-7","volume":"24","author":"MH Gul","year":"2023","unstructured":"Gul MH et al (2023) Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative. Respir Res 24(1):59. https:\/\/doi.org\/10.1186\/s12931-023-02369-7","journal-title":"Respir Res"},{"issue":"8","key":"3078_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2020.13372","volume":"324","author":"S Bilaloglu","year":"2020","unstructured":"Bilaloglu S et al (2020) Thrombosis in hospitalized patients with COVID-19 in a new York City health system. JAMA 324(8):799\u2013801. https:\/\/doi.org\/10.1001\/jama.2020.13372","journal-title":"JAMA"},{"issue":"7","key":"3078_CR30","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s11739-022-03002-z","volume":"17","author":"WC da Silveira","year":"2022","unstructured":"da Silveira WC et al (2022) Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian registry. Intern Emerg Med 17(7):1863\u20131878. https:\/\/doi.org\/10.1007\/s11739-022-03002-z","journal-title":"Intern Emerg Med"},{"key":"3078_CR31","doi-asserted-by":"publisher","first-page":"9126148","DOI":"10.1155\/2020\/9126148","volume":"2020","author":"E Kampouri","year":"2020","unstructured":"Kampouri E et al (2020) Predicting venous thromboembolic events in patients with coronavirus disease 2019 requiring hospitalization: an observational retrospective study by the COVIDIC initiative in a Swiss university hospital. Biomed Res Int 2020:9126148. https:\/\/doi.org\/10.1155\/2020\/9126148","journal-title":"Biomed Res Int"},{"issue":"1","key":"3078_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11239-020-02190-9","volume":"51","author":"B Mestre-Gomez","year":"2021","unstructured":"Mestre-Gomez B et al (2021) Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis 51(1):40\u201346. https:\/\/doi.org\/10.1007\/s11239-020-02190-9","journal-title":"J Thromb Thrombolysis"},{"key":"3078_CR33","doi-asserted-by":"publisher","unstructured":"Mouhat B et al (2020) Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. Eur Respir J 56(4). https:\/\/doi.org\/10.1183\/13993003.01811-2020","DOI":"10.1183\/13993003.01811-2020"},{"issue":"7","key":"3078_CR34","doi-asserted-by":"publisher","first-page":"e0166","DOI":"10.1097\/CCE.0000000000000166","volume":"2","author":"T Soumagne","year":"2020","unstructured":"Soumagne T et al (2020) Factors associated with pulmonary embolism among coronavirus disease 2019 acute respiratory distress syndrome: A multicenter study among 375 patients. Crit Care Explor 2(7):e0166. https:\/\/doi.org\/10.1097\/CCE.0000000000000166","journal-title":"Crit Care Explor"},{"key":"3078_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.thromres.2023.05.019","volume":"228","author":"B Bikdeli","year":"2023","unstructured":"Bikdeli B et al (2023) Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and Temporal trends: rationale and methodology of the CORONA-VTE-Network study. Thromb Res 228:94\u2013104. https:\/\/doi.org\/10.1016\/j.thromres.2023.05.019","journal-title":"Thromb Res"},{"key":"3078_CR36","doi-asserted-by":"publisher","unstructured":"Zhao Y, Long Q (2017) Variable selection in the presence of missing data: Imputation-based methods. Wiley Interdiscip Rev Comput Stat 9(5). https:\/\/doi.org\/10.1002\/wics.1402","DOI":"10.1002\/wics.1402"},{"key":"3078_CR37","first-page":"26","volume-title":"Akaike\u2019s information criterion: background, derivation, properties, and Refinements, in International encyclopedia of statistical science","author":"JE Cavanaugh","year":"2011","unstructured":"Cavanaugh JE, Neath AA (2011) Akaike\u2019s information criterion: background, derivation, properties, and Refinements, in International encyclopedia of statistical science. Springer, Berlin Heidelberg: Berlin, Heidelberg, pp 26\u201329. M. Lovric, Editor"},{"issue":"9","key":"3078_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/archinte.167.9.935","volume":"167","author":"C Huerta","year":"2007","unstructured":"Huerta C et al (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the united Kingdom. Arch Intern Med 167(9):935\u2013943. https:\/\/doi.org\/10.1001\/archinte.167.9.935","journal-title":"Arch Intern Med"},{"issue":"9","key":"3078_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","volume":"173","author":"SA Johannesdottir","year":"2013","unstructured":"Johannesdottir SA et al (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173(9):743\u2013752. https:\/\/doi.org\/10.1001\/jamainternmed.2013.122","journal-title":"JAMA Intern Med"},{"issue":"5","key":"3078_CR40","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1378\/chest.12-1446","volume":"143","author":"DJF Stuijver","year":"2013","unstructured":"Stuijver DJF et al (2013) Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest 143(5):1337\u20131342. https:\/\/doi.org\/10.1378\/chest.12-1446","journal-title":"Chest"},{"issue":"4","key":"3078_CR41","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10787-022-00987-z","volume":"30","author":"G El-Saber Batiha","year":"2022","unstructured":"El-Saber Batiha G et al (2022) COVID-19 and corticosteroids: a narrative review. Inflammopharmacology 30(4):1189\u20131205. https:\/\/doi.org\/10.1007\/s10787-022-00987-z","journal-title":"Inflammopharmacology"},{"issue":"4","key":"3078_CR42","doi-asserted-by":"publisher","first-page":"e0111","DOI":"10.1097\/CCE.0000000000000111","volume":"2","author":"J Villar","year":"2020","unstructured":"Villar J et al (2020) Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019. Crit Care Explor 2(4):e0111. https:\/\/doi.org\/10.1097\/CCE.0000000000000111","journal-title":"Crit Care Explor"},{"issue":"8","key":"3078_CR43","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/jth.14929","volume":"18","author":"AC Spyropoulos","year":"2020","unstructured":"Spyropoulos AC et al (2020) Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 18(8):1859\u20131865. https:\/\/doi.org\/10.1111\/jth.14929","journal-title":"J Thromb Haemost"},{"issue":"18","key":"3078_CR44","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","volume":"360","author":"RJ Glynn","year":"2009","unstructured":"Glynn RJ et al (2009) A randomized trial of Rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360(18):1851\u20131861. https:\/\/doi.org\/10.1056\/NEJMoa0900241","journal-title":"N Engl J Med"},{"issue":"21","key":"3078_CR45","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","volume":"374","author":"S Yusuf","year":"2016","unstructured":"Yusuf S et al (2016) Cholesterol Lowering in Intermediate-Risk persons without cardiovascular disease. N Engl J Med 374(21):2021\u20132031. https:\/\/doi.org\/10.1056\/NEJMoa1600176","journal-title":"N Engl J Med"},{"issue":"2","key":"3078_CR46","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","volume":"4","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Seidu S, Khunti K (2017) Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol 4(2):e83\u2013e. https:\/\/doi.org\/10.1016\/S2352-3026(16)30184-3","journal-title":"Lancet Haematol"},{"key":"3078_CR47","doi-asserted-by":"publisher","first-page":"e068407","DOI":"10.1136\/bmj-2021-068407","volume":"376","author":"I-S Investigators","year":"2022","unstructured":"Investigators I-S (2022) Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ 376:e068407. https:\/\/doi.org\/10.1136\/bmj-2021-068407","journal-title":"BMJ"},{"issue":"25","key":"3078_CR48","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa2309995","volume":"389","author":"R-C Investigators","year":"2023","unstructured":"Investigators R-C et al (2023) Simvastatin in critically ill patients with Covid-19. N Engl J Med 389(25):2341\u20132354. https:\/\/doi.org\/10.1056\/NEJMoa2309995","journal-title":"N Engl J Med"},{"issue":"10320","key":"3078_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","volume":"399","author":"RC Group","year":"2022","unstructured":"Group RC (2022) Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 399(10320):143\u2013151. https:\/\/doi.org\/10.1016\/S0140-6736(21)01825-0","journal-title":"Lancet"},{"issue":"8","key":"3078_CR50","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1055\/s-0042-1757634","volume":"49","author":"L Ortega-Paz","year":"2023","unstructured":"Ortega-Paz L et al (2023) COVID-19-Associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment. Semin Thromb Hemost 49(8):816\u2013832. https:\/\/doi.org\/10.1055\/s-0042-1757634","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03078-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03078-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03078-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:11:47Z","timestamp":1746065507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03078-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3078"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03078-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"13 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Outside the submitted work, Dr. Bikdeli is supported by a Career Development Award from the American Heart Association and VIVA Physicians (#938814). Dr. Bikdeli was supported by the Scott Schoen and Nancy Adams IGNITE Award and is supported by the Mary Ann Tynan Research Scientist award from the Mary Horrigan Connors Center for Women\u2019s Health and Gender Biology at Brigham and Women\u2019s Hospital, and the Heart and Vascular Center Junior Faculty Award from Brigham and Women\u2019s Hospital. Dr. Bikdeli reports that he was a consulting expert, on behalf of the plaintiff, for litigation related to two specific brand models of IVC filters. Dr. Bikdeli has not been involved in the litigation in 2022\u20132024 nor has he received any compensation in 2022\u20132024. Dr. Bikdeli reports that he is a member of the Medical Advisory Board for the North American Thrombosis Forum, and serves in the Data Safety and Monitory Board of the NAIL-IT trial funded by the National Heart, Lung, and Blood Institute, and Translational Sciences. Dr. Bikdeli is a collaborating consultant with the International Consulting Associates and the US Food and Drug Administration in a study to generate knowledge about utilization, predictors, retrieval, and safety of IVC filters. Dr. Bikdeli receives compensation as an Associated Editor for the New England Journal of Medicine Journal Watch Cardiology, as an Associate Editor for Thrombosis Research, and as an Executive Associate Editor for JACC, and is a Section Editor for Thrombosis and Haemostasis (no compensation). Dr. Piazza receives grant\/research support paid to his institution from BMS\/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Esperion, and NIH 1R01HL164717-01 and consultant fees\/honoraria from BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, and Regeneron.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}